Event Brief
FDA approves Rasonque for advanced pancreatic cancer
By The BriefBrief · Sources (5)
Filed: Aug 26, 2026 at 4:05 PM ET
Summary: The U.S. Food and Drug Administration announced approval of Rasonque, a new treatment option for people with pancreatic cancer. The approval was made public on Wednesday.
WHO: U.S. Food and Drug Administration
WHAT: Approved Rasonque as a new treatment option for people with pancreatic cancer
WHEN: Aug 26, 2026
WHERE: USA
WHY: Cause not yet established.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
🔍 Sources (5) 🔒
Judge denies TRO, allowing ICE agent to leave Texas jail
Ice
Aug 26, 2026 at 4:05 PM ET
🔒
OpenAI publishes report detailing Hugging Face agent hack
Openai
Aug 26, 2026 at 4:03 PM ET
🔒
M48 Patton range doubled after switching to diesel
M48 Patton
Aug 26, 2026 at 4:00 PM ET
🔒
Hegseth backs LaNeve nomination despite lawmaker doubts
Pete Hegseth
Aug 26, 2026 at 4:00 PM ET
🔒
Page 11 of 35379
